Myriad Genetics Inc (MYGN.O)
|Market Cap (Mil.):||$2,730.54|
|Shares Outstanding (Mil.):||72.80|
HONG KONG, June 12 - Betting on a weaker Chinese currency is the best way for investors to protect an equity portfolio as China enters a protracted period of slowing growth, said Carl Huttenlocher, chief investment officer of Myriad Asset Management.
NEW YORK, March 11 - U.S. stocks were little changed on Tuesday as investors found few reasons to push the S&P 500 above its recent record high, as tensions in Ukraine continued.
NEW YORK, March 11 - U.S. stocks were set for a flat open on Tuesday after a slight decline in the prior session left the S&P 500 within striking distance of its recent record high and amid investor caution as tensions in Ukraine continued.
- Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.
March 11 - Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.
* Futures: Dow off 8 pts, S&P off 1.25 pt, Nasdaq up 0.25 pt
March 11 - Diagnostics company Myriad Genetics Inc said a U.S. court denied a motion that would have stopped rival Ambry Genetics Corp from selling a similar version of Myriad's cancer test.
|Johnson & Johnson (JNJ.N)||$104.39||+1.18|
|Abbott Laboratories (ABT.N)||$42.38||+0.24|
|Bristol-Myers Squibb Co (BMY.N)||$50.01||-0.03|
|Bristol-Myers Squibb Co (BMYMP.PK)||$830.54||+9.12|
|Amgen, Inc. (AMGN.OQ)||$132.60||-0.08|
|Monsanto Company (MON.N)||$117.60||-3.32|
|Merck KGaA (MRCG.DE)||€63.00||-1.90|
|Gilead Sciences, Inc. (GILD.OQ)||$102.11||+1.32|
|Mylan Inc (MYL.OQ)||$47.88||-0.71|
|Allergan, Inc. (AGN.N)||$164.50||+1.37|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
"The Economy Matters" Report for MYGN: the economy's impact on MYGN's price and risk, featuring the powerful Economic Climate Rating
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.